A detailed history of Berkshire Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Berkshire Bank holds 2,869 shares of ABBV stock, worth $503,165. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,869
Previous 3,208 10.57%
Holding current value
$503,165
Previous $550,000 2.91%
% of portfolio
0.13%
Previous 0.14%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$163.84 - $199.33 $55,541 - $67,572
-339 Reduced 10.57%
2,869 $566,000
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $18,110 - $21,148
-117 Reduced 3.52%
3,208 $550,000
Q1 2024

Apr 24, 2024

SELL
$159.82 - $182.1 $185,870 - $211,782
-1,163 Reduced 25.91%
3,325 $605,000
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $3,577 - $4,029
-26 Reduced 0.58%
4,488 $695,000
Q3 2023

Nov 01, 2023

SELL
$133.59 - $154.65 $2,538 - $2,938
-19 Reduced 0.42%
4,514 $672,000
Q2 2023

Jul 12, 2023

SELL
$132.51 - $164.9 $9,673 - $12,037
-73 Reduced 1.58%
4,533 $610,000
Q1 2023

Apr 11, 2023

SELL
$144.61 - $166.54 $30,801 - $35,473
-213 Reduced 4.42%
4,606 $734,000
Q4 2022

Feb 02, 2023

SELL
$138.31 - $165.87 $123,787 - $148,453
-895 Reduced 15.66%
4,819 $779,000
Q3 2022

Nov 07, 2022

BUY
$134.21 - $153.93 $6,039 - $6,926
45 Added 0.79%
5,714 $767,000
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $26,973 - $34,292
196 Added 3.58%
5,669 $869,000
Q1 2022

Apr 21, 2022

BUY
$131.98 - $163.75 $11,878 - $14,737
90 Added 1.67%
5,473 $887,000
Q3 2021

Oct 14, 2021

SELL
$106.4 - $120.78 $15,960 - $18,117
-150 Reduced 2.71%
5,383 $581,000
Q2 2021

Jul 26, 2021

SELL
$105.21 - $117.21 $17,254 - $19,222
-164 Reduced 2.88%
5,533 $623,000
Q1 2021

Apr 19, 2021

SELL
$102.3 - $112.62 $26,188 - $28,830
-256 Reduced 4.3%
5,697 $616,000
Q4 2020

Jan 27, 2021

SELL
$80.49 - $108.67 $83,387 - $112,582
-1,036 Reduced 14.82%
5,953 $638,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $600,424 - $704,700
6,989 New
6,989 $612,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Berkshire Bank Portfolio

Follow Berkshire Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Bank, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Bank with notifications on news.